SEC EDGAR CompanyFacts fact · reporting period
CIDARA THERAPEUTICS, INC.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$63.905M{"amount": 63905000, "concept": "us-gaap:Revenues", "currency": "USD"}- Metric
- revenue
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T14:18:47.013909+02:00
Raw response SHA-256
eb499c0a06d4d2589eb64e48820b0cd0…Official-identifier path
https://factanker.com/fact/sec/cik-0001610618/revenue/2023-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 23283000, "concept": "us-gaap:Revenues", "currency": "USD"} (evidence 0001610618-25-000017)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.